ADMA Biologics Receives BioNJ 2020 Innovator Award for ASCENIV™

    NEXT STORY
    Ballad Health Reports FY20 Second Quarter Results
    PREV STORY
    Salarius Announces Closing of $11.0 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Advanced Accelerator Applications Reports 32% Sales Growth for Second Quarter 2017

    Positive CHMP Opinion for Lutetium Lu 177 Dotatate* (Lutathera®) for GEP-NETS FDA Acknowledged Receipt ...

    author_avatar
    NASDAQ Market News

    Inhibitory Effect of Innovation Pharmaceuticals’ Brilacidin on SARS-CoV-2 (COVID-19) in Primary Human Immune Cells to be Studied at Leading Public Health Research Institute

    author_avatar
    NASDAQ Market News

    Bio-Path Holdings Receives Notice of Allowance for Key U.S. Composition of Matter Patent

    HOUSTON, July 19, 2017 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company ...

    author_avatar
    NASDAQ Market News